Cleopatra Hospitals Group S.A.E. Stock Forecast for 2023 - 2025 - 2030

Updated on 04/26/2024

Stock Rating
15
Price Target
£8.00
Consensus
Outperform
Upside
26.38%
Analysts
0
Stock Rating
15
Upside
26.38%
Analysts
0
Price Target
£8.00

Cleopatra Hospitals Group S.A.E. Stock Forecast and Price Target

If the average price target of £8.00 set by distinguished experts for Cleopatra Hospitals Group S.A.E. over the past few weeks is reached this year, there would be a potential upside of approximately 26.38% from the last closing price in April, 2024. This potential increase is based on a high estimate of £8.00 and a low estimate of £6.62. If you want to invest in CLHO stock, you might also want to take a look at how its competitors are doing.

£8.00

26.38% Upside

Buy
Buy

Cleopatra Hospitals Group S.A.E. Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Cleopatra Hospitals Group S.A.E.'s Price has seen a drop from £5.08 to £0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach £0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.

2025 Fair Value Forecast
£0.00
2026 Fair Value Forecast
£0.00
2027 Fair Value Forecast
£0.00
2028 Fair Value Forecast
£0.00
2029 Fair Value Forecast
£0.00
2030 Fair Value Forecast
£0.00

Cleopatra Hospitals Group S.A.E. Revenue Forecast for 2023 - 2025 - 2030

Cleopatra Hospitals Group S.A.E.'s Revenue has seen growth In the last two years, going from £1.99B to £2.61B – a gain of 31.41% According to 0 major analysts, Cleopatra Hospitals Group S.A.E.'s Revenue will fall by 8.98% in the next year, reaching £2.38B. Professionals believe that By 2030, Cleopatra Hospitals Group S.A.E.'s Revenue will fall to £2.39B– a 8.48% decrease from its current value.

2023 Rev Forecast
£2.38B
2024 Rev Forecast
£2.26B
2025 Rev Forecast
£2.36B
2026 Rev Forecast
£2.44B
2027 Rev Forecast
£2.42B
2028 Rev Forecast
£2.37B
2029 Rev Forecast
£2.37B
2030 Rev Forecast
£2.39B

Cleopatra Hospitals Group S.A.E. Dividend per Share Forecast for 2023 - 2025 - 2030

Cleopatra Hospitals Group S.A.E. Free Cash Flow Forecast for 2023 - 2025 - 2030

Cleopatra Hospitals Group S.A.E. EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Cleopatra Hospitals Group S.A.E.'s EBITDA has increased by 25.04%, going from £467.03M to £583.96M. In the following year, 0 experts forecast that Cleopatra Hospitals Group S.A.E.'s EBITDA will decrease by 0.08%, to £583.51M. The Cleopatra Hospitals Group S.A.E. forecast is for EBITDA to reach £584.55M or grow by 0.10%.

2023 EBITDA Forecast
£0.58B
2024 EBITDA Forecast
£0.55B
2025 EBITDA Forecast
£0.59B
2026 EBITDA Forecast
£0.59B
2027 EBITDA Forecast
£0.59B
2028 EBITDA Forecast
£0.58B
2029 EBITDA Forecast
£0.58B
2030 EBITDA Forecast
£0.58B

Cleopatra Hospitals Group S.A.E. EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Cleopatra Hospitals Group S.A.E.'s EBIT has grown, increasing from £380.65M to £448.77M – an increase of 17.90%. For next year, the 0 analysts predict EBIT of £466.72M, which would mean an increase of 4.00%. Over the next eight years, the pros' prediction is EBITof £468.05M, which would mean a eight-year growth forecast of 4.30%.

2023 EBIT Forecast
£0.47B
2024 EBIT Forecast
£0.45B
2025 EBIT Forecast
£0.48B
2026 EBIT Forecast
£0.47B
2027 EBIT Forecast
£0.47B
2028 EBIT Forecast
£0.46B
2029 EBIT Forecast
£0.47B
2030 EBIT Forecast
£0.47B

Cleopatra Hospitals Group S.A.E. EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Cleopatra Hospitals Group S.A.E.'s EPS has seen a drop from £0.16 to £0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach £0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.

2025 EPS Forecast
£0.00
2026 EPS Forecast
£0.00
2027 EPS Forecast
£0.00
2028 EPS Forecast
£0.00
2029 EPS Forecast
£0.00
2030 EPS Forecast
£0.00